Last reviewed · How we verify
Nicotine Replacement Product
At a glance
| Generic name | Nicotine Replacement Product |
|---|---|
| Sponsor | Johns Hopkins University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community (NA)
- Smoking Cessation and Menstrual Cycle Phase (PHASE4)
- Cytisine vs Nicotine Replacement Therapy (NA)
- Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients (NA)
- Project DEDUCE: Digital Envirotyping to Develop Understanding of Cigarette Smoking and the Environment (PHASE4)
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder (PHASE2)
- Enhancing Smoking Cessation for African American People Everywhere (PHASE2)
- Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |